Annual CFF
-$318.60 M
+$233.90 M+42.33%
31 December 2023
Summary:
DexCom annual cash flow from financing activities is currently -$318.60 million, with the most recent change of +$233.90 million (+42.33%) on 31 December 2023. During the last 3 years, it has fallen by -$1.23 billion (-134.93%). DXCM annual CFF is now -134.93% below its all-time high of $912.10 million, reached on 31 December 2020.DXCM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$736.50 M
-$735.10 M-52507.14%
30 September 2024
Summary:
DexCom quarterly cash flow from financing activities is currently -$736.50 million, with the most recent change of -$735.10 million (-52507.14%) on 30 September 2024. Over the past year, it has dropped by -$99.10 million (-15.55%). DXCM quarterly CFF is now -178.39% below its all-time high of $939.50 million, reached on 30 June 2023.DXCM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$1.37 B
-$99.10 M-7.83%
30 September 2024
Summary:
DexCom TTM cash flow from financing activities is currently -$1.37 billion, with the most recent change of -$99.10 million (-7.83%) on 30 September 2024. Over the past year, it has dropped by -$1.68 billion (-537.11%). DXCM TTM CFF is now -248.64% below its all-time high of $918.40 million, reached on 30 June 2020.DXCM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.3% | -15.6% | -537.1% |
| 3 y3 years | -134.9% | -6919.4% | -10000.0% |
| 5 y5 years | -144.8% | -10000.0% | -291.6% |
DXCM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -134.9% | +42.3% | -178.4% | at low | -443.7% | at low |
| 5 y | 5 years | -134.9% | +42.3% | -178.4% | at low | -248.6% | at low |
| alltime | all time | -134.9% | +42.3% | -178.4% | at low | -248.6% | at low |
DexCom Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$736.50 M(>+9900.0%) | -$1.37 B(+7.8%) |
| June 2024 | - | -$1.40 M(-129.8%) | -$1.27 B(+289.4%) |
| Mar 2024 | - | $4.70 M(-100.7%) | -$325.10 M(+2.0%) |
| Dec 2023 | -$318.60 M(-42.3%) | -$631.90 M(-0.9%) | -$318.60 M(-202.0%) |
| Sept 2023 | - | -$637.40 M(-167.8%) | $312.30 M(-21.4%) |
| June 2023 | - | $939.50 M(+8288.4%) | $397.20 M(-172.7%) |
| Mar 2023 | - | $11.20 M(-1220.0%) | -$546.60 M(-1.1%) |
| Dec 2022 | -$552.50 M(-5412.5%) | -$1.00 M(-99.8%) | -$552.50 M(+0.0%) |
| Sept 2022 | - | -$552.50 M(>+9900.0%) | -$552.30 M(-5120.9%) |
| June 2022 | - | -$4.30 M(-181.1%) | $11.00 M(-26.2%) |
| Mar 2022 | - | $5.30 M(-762.5%) | $14.90 M(+43.3%) |
| Dec 2021 | $10.40 M(-98.9%) | -$800.00 K(-107.4%) | $10.40 M(+65.1%) |
| Sept 2021 | - | $10.80 M(-2800.0%) | $6.30 M(>+9900.0%) |
| June 2021 | - | -$400.00 K(-150.0%) | $0.00(-100.0%) |
| Mar 2021 | - | $800.00 K(-116.3%) | $906.40 M(-0.6%) |
| Dec 2020 | $912.10 M(+8424.3%) | -$4.90 M(-208.9%) | $912.10 M(-0.5%) |
| Sept 2020 | - | $4.50 M(-99.5%) | $916.90 M(-0.2%) |
| June 2020 | - | $906.00 M(>+9900.0%) | $918.40 M(+7366.7%) |
| Mar 2020 | - | $6.50 M(-6600.0%) | $12.30 M(+15.0%) |
| Dec 2019 | $10.70 M(-98.5%) | -$100.00 K(-101.7%) | $10.70 M(-98.5%) |
| Sept 2019 | - | $6.00 M(-6100.0%) | $712.40 M(+0.1%) |
| June 2019 | - | -$100.00 K(-102.0%) | $711.80 M(+0.1%) |
| Mar 2019 | - | $4.90 M(-99.3%) | $711.10 M(+0.1%) |
| Dec 2018 | $710.40 M(+78.0%) | $701.60 M(>+9900.0%) | $710.40 M(+7882.0%) |
| Sept 2018 | - | $5.40 M(-775.0%) | $8.90 M(+14.1%) |
| June 2018 | - | -$800.00 K(-119.0%) | $7.80 M(-97.6%) |
| Mar 2018 | - | $4.20 M(+4100.0%) | $323.00 M(-19.1%) |
| Dec 2017 | $399.10 M(+4827.2%) | $100.00 K(-97.7%) | $399.10 M(-0.1%) |
| Sept 2017 | - | $4.30 M(-98.6%) | $399.50 M(-0.2%) |
| June 2017 | - | $314.40 M(+291.5%) | $400.30 M(+369.8%) |
| Mar 2017 | - | $80.30 M(>+9900.0%) | $85.20 M(+951.9%) |
| Dec 2016 | $8.10 M(-51.8%) | $500.00 K(-90.2%) | $8.10 M(-17.3%) |
| Sept 2016 | - | $5.10 M(-828.6%) | $9.80 M(-3.0%) |
| June 2016 | - | -$700.00 K(-121.9%) | $10.10 M(-33.1%) |
| Mar 2016 | - | $3.20 M(+45.5%) | $15.10 M(-10.1%) |
| Dec 2015 | $16.80 M(-22.9%) | $2.20 M(-59.3%) | $16.80 M(-13.8%) |
| Sept 2015 | - | $5.40 M(+25.6%) | $19.50 M(-3.5%) |
| June 2015 | - | $4.30 M(-12.2%) | $20.20 M(+15.4%) |
| Mar 2015 | - | $4.90 M(0.0%) | $17.50 M(-19.7%) |
| Dec 2014 | $21.80 M | $4.90 M(-19.7%) | $21.80 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $6.10 M(+281.3%) | $21.80 M(+23.9%) |
| June 2014 | - | $1.60 M(-82.6%) | $17.60 M(-3.8%) |
| Mar 2014 | - | $9.20 M(+87.8%) | $18.30 M(+55.1%) |
| Dec 2013 | $11.80 M(+15.7%) | $4.90 M(+157.9%) | $11.80 M(-16.9%) |
| Sept 2013 | - | $1.90 M(-17.4%) | $14.20 M(+4.4%) |
| June 2013 | - | $2.30 M(-14.8%) | $13.60 M(+15.3%) |
| Mar 2013 | - | $2.70 M(-63.0%) | $11.80 M(+15.7%) |
| Dec 2012 | $10.20 M(-86.3%) | $7.30 M(+461.5%) | $10.20 M(+244.2%) |
| Sept 2012 | - | $1.30 M(+160.0%) | $2.96 M(+13.0%) |
| June 2012 | - | $500.00 K(-54.5%) | $2.62 M(-96.5%) |
| Mar 2012 | - | $1.10 M(+1646.0%) | $73.84 M(-0.5%) |
| Dec 2011 | $74.20 M(+6.6%) | $63.00 K(-93.4%) | $74.20 M(-30.9%) |
| Sept 2011 | - | $958.00 K(-98.7%) | $107.35 M(-0.6%) |
| June 2011 | - | $71.72 M(+4802.0%) | $108.02 M(+188.2%) |
| Mar 2011 | - | $1.46 M(-95.6%) | $37.47 M(-46.2%) |
| Dec 2010 | $69.60 M(+56.8%) | $33.21 M(+1943.9%) | $69.60 M(+92.1%) |
| Sept 2010 | - | $1.63 M(+38.7%) | $36.24 M(+5.4%) |
| June 2010 | - | $1.17 M(-96.5%) | $34.39 M(+5.1%) |
| Mar 2010 | - | $33.59 M(<-9900.0%) | $32.73 M(-26.3%) |
| Dec 2009 | $44.38 M(+1536.4%) | -$146.00 K(-35.4%) | $44.38 M(+0.8%) |
| Sept 2009 | - | -$226.00 K(-54.0%) | $44.02 M(-0.1%) |
| June 2009 | - | -$491.00 K(-101.1%) | $44.06 M(-0.4%) |
| Mar 2009 | - | $45.24 M(-9094.4%) | $44.24 M(+1531.4%) |
| Dec 2008 | $2.71 M(-94.2%) | -$503.00 K(+171.9%) | $2.71 M(-9.9%) |
| Sept 2008 | - | -$185.00 K(-40.3%) | $3.01 M(-4.9%) |
| June 2008 | - | -$310.00 K(-108.4%) | $3.17 M(+14.4%) |
| Mar 2008 | - | $3.71 M(-1918.6%) | $2.77 M(-94.1%) |
| Dec 2007 | $46.60 M(-9.0%) | -$204.00 K(+603.4%) | $46.60 M(-1.2%) |
| Sept 2007 | - | -$29.00 K(-95.9%) | $47.19 M(-3.1%) |
| June 2007 | - | -$709.00 K(-101.5%) | $48.69 M(-50.4%) |
| Mar 2007 | - | $47.54 M(>+9900.0%) | $98.25 M(+91.8%) |
| Dec 2006 | $51.22 M(+0.9%) | $384.00 K(-73.9%) | $51.22 M(+0.7%) |
| Sept 2006 | - | $1.47 M(-97.0%) | $50.85 M(+3.0%) |
| June 2006 | - | $48.86 M(+9593.7%) | $49.35 M(-4.1%) |
| Mar 2006 | - | $504.00 K(+2830.2%) | $51.46 M(+1.4%) |
| Dec 2005 | $50.74 M(+137.3%) | $17.20 K(-155.5%) | $50.74 M(+0.0%) |
| Sept 2005 | - | -$31.00 K(-100.1%) | $50.72 M(-0.1%) |
| June 2005 | - | $50.97 M(<-9900.0%) | $50.76 M(<-9900.0%) |
| Mar 2005 | - | -$213.20 K | -$213.20 K |
| Dec 2004 | $21.38 M(>+9900.0%) | - | - |
| Dec 2003 | $33.40 K | - | - |
FAQ
- What is DexCom annual cash flow from financing activities?
- What is the all time high annual CFF for DexCom?
- What is DexCom annual CFF year-on-year change?
- What is DexCom quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for DexCom?
- What is DexCom quarterly CFF year-on-year change?
- What is DexCom TTM cash flow from financing activities?
- What is the all time high TTM CFF for DexCom?
- What is DexCom TTM CFF year-on-year change?
What is DexCom annual cash flow from financing activities?
The current annual CFF of DXCM is -$318.60 M
What is the all time high annual CFF for DexCom?
DexCom all-time high annual cash flow from financing activities is $912.10 M
What is DexCom annual CFF year-on-year change?
Over the past year, DXCM annual cash flow from financing activities has changed by +$233.90 M (+42.33%)
What is DexCom quarterly cash flow from financing activities?
The current quarterly CFF of DXCM is -$736.50 M
What is the all time high quarterly CFF for DexCom?
DexCom all-time high quarterly cash flow from financing activities is $939.50 M
What is DexCom quarterly CFF year-on-year change?
Over the past year, DXCM quarterly cash flow from financing activities has changed by -$99.10 M (-15.55%)
What is DexCom TTM cash flow from financing activities?
The current TTM CFF of DXCM is -$1.37 B
What is the all time high TTM CFF for DexCom?
DexCom all-time high TTM cash flow from financing activities is $918.40 M
What is DexCom TTM CFF year-on-year change?
Over the past year, DXCM TTM cash flow from financing activities has changed by -$1.68 B (-537.11%)